Filing Flows › Orthofix Medical (OFIX) › Q2 FY26 › vs Q1 FY26
Orthofix Medical (OFIX) Q2 FY26 vs Q1 FY26 (quarter over quarter)
Orthofix Medical's revenue rose $14.2M (+7%) from $197M in Q1 FY26 to $211M in Q2 FY26. The biggest changes: Global Spine +$9.4M (+6%); Global Limb Reconstruction +$4.8M (+15%).
Orthofix Medical, Q2 FY26: revenue $211M (+4% year over year), operating margin -3.9%, net loss $15.8M, operating cash flow −$6.2M. The chart draws each line against Q1 FY26, the increases inside each band.
Every line
| Line | Q2 FY26 | Q1 FY26 | Change | % |
|---|---|---|---|---|
| Global Spine | $173M | $164M | $9.4M | +6% |
| Global Limb Reconstruction | $37.7M | $32.9M | $4.8M | +15% |
| Revenue | $211M | $197M | $14.2M | +7% |
| Net loss | $15.8M | $20.9M | −$5.1M | -24% |
| Costs & expenses | $227M | $218M | $9.1M | +4% |
| Operating costs | $219M | $211M | $7.9M | +4% |
| Interest & other, net | $6.9M | $6.4M | $465K | +7% |
| Income tax | $801K | $74K | $727K | +982% |
| Cost of revenue | $61.2M | $57.2M | $4.1M | +7% |
| Research & development | $15.9M | $15.3M | $624K | +4% |
| SG&A | $138M | $135M | $3.1M | +2% |
| Other operating costs | $3.9M | $3.8M | $116K | +3% |
| Operating cash sources | $27.2M | $37.6M | −$10.4M | -28% |
| Depreciation & amortization | $13.3M | $13.5M | −$220K | -2% |
| Share-based compensation | $7.7M | $6.5M | $1.2M | +18% |
| Cash used in operations | $6.2M | $17.6M | −$11.4M | -65% |
| Net loss absorbed | $15.8M | $20.9M | −$5.1M | -24% |
| Working capital & other | $11.4M | $16.7M | −$5.3M | -32% |
Questions
How much did Orthofix Medical's revenue grow quarter over quarter in Q2 FY26?
Orthofix Medical's revenue rose $14.2M (+7%) from $197M in Q1 FY26 to $211M in Q2 FY26.
What drove Orthofix Medical's revenue change in Q2 FY26?
Global Spine +$9.4M (+6%); Global Limb Reconstruction +$4.8M (+15%).